Tech Company M&A Transactions
Solexa Acquisition
Solexa was acquired by Illumina. The transaction became public on 11/13/2006. Illumina said the transaction price was $600 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/13/2006
Transaction Type
M&A
Amount
$600,000,000
M&A Terms
At Solexa's Friday closing price, the offer represents a 44 percent premium. Solexa shot up to $12.90 in midday trading upon the news. Illumina stock was down about 8 percent to $40.36.In addition to the stock, Illumina has agreed to invest $50 million in Solexa in exchange for newly issued Solexa shares, subject to customary closing conditions.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
25861 Industrial Boulevard
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Website
Email Address
Not Recorded
Overview
Solexa, Inc. is developing and preparing to commercialize a new platform for genetic analysis, based on Sequencing-by-Synthesis (SBS) and Cluster molecular arrays. This one platform is expected to support many types of genetic analysis, including DNA sequencing, gene expression, genotyping and micro-RNA analysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John West
Browse more venture capital transactions:
Prev: 11/13/2006: Ceptaris Therapeutics venture capital transaction
Next: 11/13/2006: Mascoma venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs